(Q43109559)

English

A prospective observational study of the effects of treatment with extended-release tolterodine on health-related quality of life of patients suffering overactive bladder syndrome in Sweden

scientific article published in April 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

A prospective observational study of the effects of treatment with extended-release tolterodine on health-related quality of life of patients suffering overactive bladder syndrome in Sweden (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ralph Peeker

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Göran Samsioe

2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Jan Kowalski

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Ann-Sofie Andersson

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Agneta Bergqvist

5

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

publication date

1 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Scandinavian Journal of Urology and Nephrology

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

138-146

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

The economic impact of overactive bladder syndrome in six Western countries.

1 reference

https://api.crossref.org/works/10.3109%2F00365591003709468

21 January 2018

The current and future burden and cost of overactive bladder in five European countries.

1 reference

https://api.crossref.org/works/10.3109%2F00365591003709468

21 January 2018

Psychosocial impact of urinary incontinence in the community-dwelling population

1 reference

https://api.crossref.org/works/10.3109%2F00365591003709468

21 January 2018

Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey.

1 reference

https://api.crossref.org/works/10.3109%2F00365591003709468

21 January 2018

The quality of life in women with urinary incontinence as measured by the sickness impact profile

1 reference

https://api.crossref.org/works/10.3109%2F00365591003709468

21 January 2018

Methods used to manage urinary incontinence by older adults in the community

1 reference

https://api.crossref.org/works/10.3109%2F00365591003709468

21 January 2018

Tolterodine--a new bladder selective muscarinic receptor antagonist: preclinical pharmacological and clinical data

1 reference

https://api.crossref.org/works/10.3109%2F00365591003709468

21 January 2018

Evidence for the efficacy and safety of tolterodine in the treatment of overactive bladder

1 reference

https://api.crossref.org/works/10.3109%2F00365591003709468

21 January 2018

The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F00365591003709468

21 January 2018

Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q

1 reference

https://api.crossref.org/works/10.3109%2F00365591003709468

21 January 2018

The responsiveness of the Overactive Bladder Questionnaire (OAB-q).

1 reference

https://api.crossref.org/works/10.3109%2F00365591003709468

21 January 2018

A multicenter, prospective, open-label study of tolterodine extended-release 4 mg for overactive bladder: the speed of onset of therapeutic assessment trial (STAT).

1 reference

https://api.crossref.org/works/10.3109%2F00365591003709468

21 January 2018

Treatment of overactive bladder: long-term tolerability and efficacy of tolterodine

1 reference

https://api.crossref.org/works/10.3109%2F00365591003709468

21 January 2018

Identifiers

10.3109/00365591003709468

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43109559&oldid=1981169431"